CNS Pharmaceuticals | Press Releases

Overview Financials & Filings Press Releases Events Corporate Governance Stock Information FAQS

Press Releases

Title

Date

12 September, 2024

CNS Pharmaceuticals Regains Compliance with Nasdaq Equity Requirement

04 September, 2024

CNS Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

27 August, 2024

CNS Pharmaceuticals to Participate in at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinar

22 August, 2024

CNS Pharmaceuticals to Participate in Virtual Investor CEO Connect Segment

15 August, 2024

CNS Pharmaceuticals Reports Second Quarter 2024 Financial Results

30 July, 2024

CNS Pharmaceuticals Expands Pipeline with In License of Late Stage Novel Potential Blood Brain Barrier Permeable Abeotaxane for Treatment of Brain Malignancies

25 July, 2024

CNS Pharmaceuticals Announces Acceptance of Abstract for Poster Presentation at the 2024 SNO ASCO CNS Cancer Conference

16 July, 2024

CNS Pharmaceuticals to Participate in the Virtual Investor Closing Bell Series

There are no press releases that match the selected filters.

View More

Stay Updated

All Press Releases
All SEC Filings
End of Day Stock Data
Weekly

At least one type of alert must be selected.

An email address is required.

Your email alerts were set.

The following alerts could not be set: